XML 14 R4.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Income Statement [Abstract]        
Net Sales $ 15,895,971 $ 14,845,788 $ 31,752,510 $ 30,405,227
Cost of Sales 15,015,404 14,112,639 29,759,017 28,661,686
Gross Profit 880,567 733,149 1,993,493 1,743,541
Selling and Marketing 1,996,595 2,218,997 4,069,393 5,321,375
General and Administrative 2,871,013 5,496,670 8,144,445 11,717,169
Settlement Expense 0 430,000 0 430,000
Research and Product Development 1,616,393 2,958,276 3,437,881 3,455,552
Operating Loss (5,603,434) (10,370,794) (13,658,226) (19,180,555)
Other Income (Expense)        
Realized Gain on Investments 2,065 4,135 3,994 18,023
Warrant Modification Expense (837,322) 0 (837,322) 0
Interest Expense (520,604) 0 (622,556) 0
Interest Income 66,750 74,476 237,827 192,002
Total Other Income (1,289,111) 78,611 (1,218,057) 210,025
Net Loss $ (6,892,545) $ (10,292,183) $ (14,876,283) $ (18,970,530)
Basic and Diluted Net Loss per Share (in dollars per share) $ (0.10) $ (0.18) $ (0.22) $ (0.33)
Basic and Diluted Weighted Average Shares Outstanding (in shares) 69,428,574 58,216,066 68,473,407 57,660,947